| Literature DB >> 31759294 |
Anna D Wagner1, Florian Lordick2, Heike I Grabsch3, Masanori Terashima4, Mitsumi Terada5, Takaki Yoshikawa6, Narikazu Boku7, Kozo Kataoka8, Elizabeth C Smyth9, Murielle Mauer10, Karin Haustermans11, Markus H Moehler12.
Abstract
The aim of this manuscript is to discuss the viewpoint of the European Organisation for Research and Treatment of Cancer (EORTC) Gastric Cancer Taskforce and Japan Clinical Oncology Group (JCOG) Gastric Cancer Study Group on the current challenges in the multidisciplinary management of stage II-III gastric and gastro-oesophageal junction (GEJ) cancer. We seek to outline how these challenges are addressed in current trials of both groups. Key elements of future trials of EORTC and JCOG in this indication are described, and a joint vision on how multidisciplinary research of gastric and GEJ cancer patients should be organised is outlined.Entities:
Keywords: Adjuvant; Chemotherapy; EORTC; Gastric; Immunotherapy; JCOG; Perioperative
Mesh：
Year: 2019 PMID： 31759294 DOI： 10.1016/j.ejca.2019.09.006
Source DB: PubMed Journal: Eur J Cancer ISSN： 0959-8049 Impact factor: 9.162